Neuropace Inc.

NPCE·NASDAQ·$16.68Share Price as of 11/2·$569MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/03/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report07/28/26 8-KCurrent report06/08/26 8-KCurrent report05/12/26 8-KCurrent report03/03/26

Prospectuses and Registrations

S-8Registration of securities for employees03/03/26 S-8Registration of securities for employees03/04/25 424B5Prospectus supplement02/18/25 424B5Prospectus supplement02/14/25 S-8Registration of securities for employees03/05/24

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 DEF 14ADefinitive proxy04/22/25 DEFA14AAdditional proxy materials04/22/25 DEF 14ADefinitive proxy04/22/24

Ownership

Form 4Insider transaction09/25/26 Form 4Insider transaction09/21/26 Form 4Insider transaction09/04/26 SC 13G/ABeneficial ownership (amended)09/04/26 Form 4Insider transaction08/28/26

Other

ARSAnnual report to shareholders04/21/26 ARSAnnual report to shareholders04/22/25 ARSAnnual report to shareholders04/22/24 ARSAnnual report to shareholders04/25/23 EFFECTRequest for effectiveness11/22/22